Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study

Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine

(2011) Wolfram Gronwald et al.   KIDNEY INTERNATIONAL

Human urinary peptide database for multiple disease biomarker discovery

(2011) Justyna Siwy et al.   Proteomics Clinical Applications

Determinants of Renal Disease Variability in ADPKD

(2010) Peter C. Harris et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-sectional Analysis

(2010) Esther Meijer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease

(2010) E. Meijer et al.   Clinical Journal of the American Society of Nephrology

The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation

(2010) S. Mangos et al.   Disease Models & Mechanisms

Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals

(2010) Christian Delles et al.   JOURNAL OF HYPERTENSION

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

(2010) David M. Good et al.   MOLECULAR & CELLULAR PROTEOMICS

Molecular diagnostics for autosomal dominant polycystic kidney disease

(2010) Peter C. Harris et al.   Nature Reviews Nephrology

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

(2010) Andreas L. Serra et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy

(2010) Alaa Alkhalaf et al.   PLoS One

Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics

(2009) E. Schiffer et al.   CLINICAL CANCER RESEARCH

Evaluation of Urinary Biomarkers for Coronary Artery Disease, Diabetes, and Diabetic Kidney Disease

(2009) Janet K. Snell-Bergeon et al.   Diabetes Technology & Therapeutics

Autosomal Dominant Polycystic Kidney Disease: New Treatment Options and How to Test Their Efficacy

(2009) Rudolf P. Wüthrich et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease

(2009) Andreas D. Kistler et al.   KIDNEY INTERNATIONAL

Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

(2009) Marion Haubitz et al.   MOLECULAR & CELLULAR PROTEOMICS

Urinary proteome pattern in children with renal Fanconi syndrome

(2009) J. Drube et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Unified Criteria for Ultrasonographic Diagnosis of ADPKD

(2008) Y. Pei et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months

(2008) Andreas D. Kistler et al.   KIDNEY INTERNATIONAL

Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments

(2008) Harald Mischak et al.   MASS SPECTROMETRY REVIEWS

Overexpression of innate immune response genes in a model of recessive polycystic kidney disease

(2007) M. Mrug et al.   KIDNEY INTERNATIONAL